Ginger (Zingiber officinale), known as Gan Jiang in Traditional Chinese Medicine, is among the oldest and most studied medicinal plants in the world. Used for over three thousand years to treat digestive disorders, this pungent rhizome continues to fascinate researchers who are attempting to scientifically validate its antiemetic properties. Hundreds of rigorous clinical trials have explored its effectiveness against various types of nausea, revealing results that are sometimes spectacular, sometimes more nuanced.
The active compounds responsible for the antiemetic effects
The effectiveness of ginger relies primarily on two families of compounds: gingerols and shogaols. Gingerols are the dominant compound in fresh ginger, representing 7 to 14 milligrams per gram in dried powder, compared to only 2 to 2.8 milligrams per gram in the fresh rhizome. Shogaols, thermal degradation products of gingerols, appear during drying or cooking and possess a distinct pharmacological activity.
A mass spectrometry analysis published in 2016 revealed that powdered ginger teas contain only 0.8 milligrams per gram of gingerol-related compounds, explaining why more concentrated ginger products (powder or capsules) generally show greater effectiveness than weak infusions. This considerable variation in concentration between preparations complicates comparisons of studies and underscores the importance of standardization.
In vitro studies have demonstrated that these compounds act as antagonists of 5-HT3 serotonergic and M-cholinergic receptors, the same targets as conventional antiemetic drugs such as ondansetron. Gingerols also block cation uptake by the 5-HT3 receptor channel and reduce contractions of the isolated guinea pig ileum, a classic model for studying gastrointestinal motility.
Nausea during pregnancy: the best-validated application
A 2014 meta-analysis combining twelve randomized controlled trials and 1,278 pregnant women established that ginger significantly improves nausea symptoms compared to placebo. The mean difference on the measurement scales reached 1.20 points with a confidence interval of 0.56 to 1.84 and a p-value of 0.0002, indicating a robust and statistically significant effect.
Regarding vomiting, the results are more mixed. The same meta-analysis shows a trend toward improvement, with an average difference of 0.72 episodes of vomiting, but this difference does not reach statistical significance, with a confidence interval of -0.03 to 1.46 and a p-value of 0.06. Ginger therefore appears to be more effective against nausea than against vomiting itself.
An important finding concerns the optimal dosage. Subgroup analyses consistently favor doses below 1500 milligrams per day for nausea relief. Above this dose, effectiveness does not necessarily improve, suggesting the existence of a plateau effect. The dose usually recommended is between 1000 and 1500 milligrams of ginger per day, divided into several doses.
Four trials compared ginger to vitamin B6, a first-line treatment recommended by several medical authorities. These studies, which included 625 women, found no significant difference in effectiveness between the two interventions, positioning ginger as an equivalent and natural alternative to conventional treatment.
Post-chemotherapy nausea and vomiting
A 2022 systematic review including 23 randomized controlled trials assessed the effect of ginger on chemotherapy-induced nausea and vomiting. Despite the use of potent antiemetics such as 5-HT3 antagonists, up to 70% of patients receiving highly emetogenic chemotherapy continue to experience nausea and vomiting.
A 2023 Australian study of 103 chemotherapy-naïve adults administered four standardized ginger capsules daily (totaling 84 milligrams of active gingerols and shogaols) for five consecutive days over three cycles of chemotherapy. The results show a clinically significant lower incidence of delayed nausea and vomiting in the ginger group in cycle 2 (53% vs. 75% for nausea, 4% vs. 27% for vomiting) and in cycle 3 (49% vs. 79% and 2% vs. 23%, respectively).
Even more impressively, the incidence of malnutrition was significantly lower in the ginger group in cycle 3 (18% vs. 41%), demonstrating that improved symptom control translates into tangible clinical benefits for patients’ nutritional status. No serious adverse events were reported.
A large, multicenter American study of 576 patients confirmed that ginger significantly reduces acute chemotherapy-induced nausea when added to standard antiemetic therapy. However, the effect remains modest and is not effective for all patients or all types of chemotherapy.
Postoperative Nausea and Vomiting: Conflicting Results
A 2018 Hungarian meta-analysis of ten randomized trials and 918 patients evaluated the effectiveness of ginger on postoperative nausea and vomiting. The results show that ginger significantly reduces symptom severity as measured by a visual analog scale, with a standardized mean difference of -0.247 favoring ginger.
However, the effect on the incidence of nausea and vomiting and on the demand for rescue antiemetic medication did not reach statistical significance compared to placebo. The authors suggest that this disappointing result could be explained by underdosing in most of the analyzed studies. The 1-gram dose administered before surgery, which is frequently used, appears insufficient to produce a robust clinical effect.
An older systematic review from 2000 concluded that ginger showed efficacy equivalent to metoclopramide in two out of three studies, but that pooled data did not indicate a significant difference compared to placebo. This inconsistency between positive individual studies and disappointing meta-analyses likely reflects the heterogeneity of protocols, doses, and types of surgery.
Safety Profile and Precautions for Use
A comprehensive review of 109 randomized controlled trials on ginger and human health, published in 2020, concluded that only 43 studies (39.4%) met the criterion of “high quality of evidence.” Nevertheless, reported adverse effects generally remained mild and infrequent: mild heartburn, reflux, and occasional diarrhea.
The largest safety study during pregnancy, a large Norwegian cohort study, detected no increased risk of birth defects, stillbirths, or obstetric complications in women consuming ginger during the first trimester. However, some Nordic countries, such as Finland and Denmark, have issued warnings about ginger supplements as a precaution, due to theoretical concerns about fetal development. Ginger has recognized anticoagulant properties, which may potentiate the effects of anticoagulant or antiplatelet medications. Patients taking warfarin, aspirin, or clopidogrel should consult their doctor before taking any supplements. Similarly, a potential interaction exists with certain drugs metabolized by cytochrome P450.
- Methodological limitations of current research
- Despite hundreds of studies, ginger research suffers from several recurring weaknesses. The major problem is the insufficient standardization of preparations: powder, aqueous extract, ethanolic extract, fresh ginger, dried ginger, capsules, ginger biscuits… Each form contains varying concentrations of active ingredients, making comparisons difficult.
- Very few studies precisely quantify the gingerol and shogaol content of their preparations. Of the twelve trials in the meta-analysis on morning sickness, none reported chemical analysis of the active compounds. Of seven studies concerning chemotherapy, only two did so. This gap prevents the establishment of precise dosage recommendations based on the active compounds rather than the raw weight of ginger.
- The populations studied are often small, the evaluation systems are not standardized, and the follow-up period is short. These limitations, acknowledged by the researchers themselves, call for larger-scale trials with standardized preparations and rigorous protocols to refine our understanding of this ancient plant.
- Cited scientific sources :
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4818021/
- https://pubmed.ncbi.nlm.nih.gov/10793599/
- https://www.mdpi.com/2072-6643/14/23/4982
- https://www.sciencedirect.com/science/article/pii/S2212267223015265
- https://pubmed.ncbi.nlm.nih.gov/31225678/
